Skip to content

Author

K. Ying

We have 3 of 45 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Integration of proteomic aging clocks in a phase 2a clinical trial supports simultaneous geroprotective assessment.

Drugs for aging-related diseases may modulate aging itself, but standard clinical trial designs cannot detect such effects. Aging clocks could close this gap, but epigenetic models often yield inconsistent, hard-to-interpret results. In contrast, proteomic clocks, by tracking the immediate effectors of biological chang...

Alex Zhavoronkov, F. Galkin, Shan Chen et al. · 1 citation
Open access Aug 2026

Novel Exploratory Transcriptomic Candidates as Biomarkers and Cancer Hallmark Fingerprints for Ovarian Endometroid and Clear Cell Carcinomas in Women

Background: Endometriosis-associated ovarian cancers (EAOCs), encompassing clear cell (CC) and endometrioid carcinomas (EC), constitute distinct biological entities yet lack robust biomarkers for precise classification, prognostication, and therapeutic decision-making in women. Therefore, we aimed to describe novel bio...

Pawel Kordowitzki, K. Ying · 0 citations
#computer vision Oct 2025

ECloudGen: leveraging electron clouds as a latent variable to scale up structure-based molecular design

This study presents ECloudGen, which uses latent diffusion to generate electron clouds from protein pockets and decodes them into molecules, and adopts two-stage training, which expands the chemical space accessible to generative drug design.

Odin Zhang, Jieyu Jin, Zhenxing Wu et al. · 4 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.